Keson-Brookes Maiken

CIK 00016938053 companiesDUBLIN 2, L2

SEC Profile

Transactions

Companies

Filings

CIK

0001693805

Recent Transactions

31 trades

Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−31,200→ 0 total
Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−65,000→ 0 total
Disposition to Issuer
Mural Oncology plc
Ordinary Shares
2025-12-05−68,834→ 0 total
Disposition to Issuer
Mural Oncology plc
Stock Option (right to buy)
2025-12-05−54,242→ 0 total
Sale
Mural Oncology plc
Ordinary Shares
2025-07-22$2.48/sh−2,572→ 68,834 total
Sale
Mural Oncology plc
Ordinary Shares
2025-07-18$2.48/sh−2,158→ 71,406 total
Sale
Mural Oncology plc
Ordinary Shares
2025-03-05$3.45/sh−1,469→ 73,564 total
Sale
Mural Oncology plc
Ordinary Shares
2025-03-04$3.36/sh−1,262→ 75,033 total
Award
Mural Oncology plc
Stock Option (right to buy)
2025-03-03+65,000→ 65,000 total
Award
Mural Oncology plc
Ordinary Shares
2025-03-03+35,000→ 76,295 total
Sale
Mural Oncology plc
Ordinary Shares
2024-12-23$3.27/sh−2,555→ 41,295 total
Sale
Mural Oncology plc
Ordinary Shares
2024-07-18$3.41/sh−2,157→ 43,850 total
Award
Mural Oncology plc
Stock Option (right to buy)
2024-03-01+31,200→ 31,200 total
Award
Mural Oncology plc
Ordinary Shares
2024-03-01+16,800→ 46,007 total
Award
Mural Oncology plc
Stock Option (right to buy)
2023-12-14+54,242→ 54,242 total
Award
Mural Oncology plc
Ordinary Shares
2023-12-14+29,207→ 29,207 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2022-02-01$6.57/sh−2,732→ 5,343 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2022-01-31+143,750→ 143,750 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-31+34,500→ 34,500 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2022-01-29+8,075→ 8,075 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Restricted Stock Units
2022-01-29−8,075→ 24,225 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2021-03-15−25,000→ 225,000 total
Exercise/Conversion
Rubius Therapeutics, Inc.
Common Stock
2021-03-15$7.70/sh+25,000→ 25,000 total
Sale
Rubius Therapeutics, Inc.
Common Stock
2021-03-15$20.24/sh−25,000→ 0 total
Award
Rubius Therapeutics, Inc.
Restricted Stock Units
2021-01-29+32,300→ 32,300 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2021-01-29+142,500→ 142,500 total
Award
Rubius Therapeutics, Inc.
Stock Option (Right to Buy)
2019-11-29+250,000→ 250,000 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2017-01-27+43,000→ 43,000 total
Award
uniQure N.V.$QURE
Performance Share Unit
2017-01-27+43,250→ 43,250 total
Award
uniQure N.V.$QURE
Stock Option (Right to Buy)
2017-01-27+43,250→ 43,250 total
Award
uniQure N.V.$QURE
Performance Share Unit
2017-01-27+43,500→ 43,500 total

Companies

Recent Filings

Address

C/O MURAL ONCOLOGY PLC 10 EARLSFORT TERRACE

DUBLIN 2, L2, D02 T380

View on SEC.gov